TEVA - SA Asks: How could higher India tariffs impact drug stocks?
2025-08-07 13:00:58 ET
More on Merck, Eli Lilly, etc.
- Perrigo Company plc 2025 Q2 - Results - Earnings Call Presentation
- Perrigo Company plc (PRGO) Q2 2025 Earnings Call Transcript
- Amneal Pharmaceuticals, Inc. 2025 Q2 - Results - Earnings Call Presentation
- Can Eli Lilly keep its GLP-1 crown? Q2 earnings will tell
- Perrigo outlines $2.90–$3.10 EPS target and reaffirms full-year guidance amid strategic divestitures and brand share gains